Auranofin is a potent suppressor of osteosarcoma metastasis

Osteosarcoma (OS) accounts for 56% of malignant bone cancers in children and adolescents. Patients with localized disease rarely develop metastasis; however, pulmonary metastasis occurs in approximately 50% of patients and leads to a 5-year survival rate of only 10–20%. Therefore, identifying the ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Topkas, Eleni, Cai, Na, Cumming, Andrew, Hazar-Rethinam, Mehlika, Gannon, Orla Margaret, Burgess, Melinda, Saunders, Nicholas Andrew, Endo-Munoz, Liliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808036/
https://www.ncbi.nlm.nih.gov/pubmed/26573231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808036/
https://www.ncbi.nlm.nih.gov/pubmed/26573231

Ejemplares similares